Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung-Che Chang

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Archives of Pathology & Laboratory Medicine|July 13, 2006
Detection of the JAK2(V617F) mutation in myeloproliferative disorders by melting curve analysis using the LightCycler systemRandall J Olsen, Zhouwen Tang, Daniel H Farkas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 10, 2010
Using oligonucleotide aptamer probes for immunostaining of formalin-fixed and paraffin-embedded tissuesZihua Zeng, Peng Zhang, Nianxi Zhao, et al.
Journal of Hematopathology|August 12, 2009
The implication of identifying JAK2 ( V617F ) in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosisRandall J Olsen, Cherie H Dunphy, Dennis P O'Malley, et al.
International Journal of Surgical Pathology|November 27, 2020
Local ALK-Positive Histiocytosis With Unusual Morphology and Novel <i>TRIM33-ALK</i> Gene FusionTien Anh N Tran, Kenneth Tou En Chang, Chik Hong Kuick, et al.
Transplantation and Cellular Therapy|May 5, 2021
Comparison of Myeloablative versus Reduced-Intensity Conditioning Regimens in Allogeneic Stem Cell Transplantation Recipients with Acute Myelogenous Leukemia with Measurable Residual Disease-Negative Disease at the Time of Transplantation: A Retrospective Cohort StudyJames Yu, Yuan Du, Sarfraz Ahmad, et al.
American Journal of Clinical Pathology|September 17, 2008
p38 mitogen-activated protein kinase has different degrees of activation in myeloproliferative disorders and myelodysplastic syndromesMunir Shahjahan, Cherie H Dunphy, April Ewton, et al.
Clinical Transplantation|January 6, 2004
Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorderVasundhara Ganne, Nauman Siddiqi, Bal Kamaplath, et al.
Diagnostic Pathology|September 27, 2006
Prevention of an additional surgery for regional lymphadenectomy in melanoma: rapid intraoperative immunostaining of sentinel lymph node imprint smearsVinod B Shidham, Richard Komorowski, Marcelle Neuberg, et al.
Blood|February 21, 2004
Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemiaMichael D Rosenblum, James L LaBelle, Chung-Che Chang, et al.
Cytojournal|March 24, 2017
Detection of BRAF mutation in the cytocentrifugation supernatant fluid from fine-needle aspiration of thyroid lesions may enhance the diagnostic yieldAshley E Brown, Khin Sandar Lim, George Corpus, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Archives of Pathology & Laboratory Medicine|July 13, 2006
Detection of the JAK2(V617F) mutation in myeloproliferative disorders by melting curve analysis using the LightCycler systemRandall J Olsen, Zhouwen Tang, Daniel H Farkas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 10, 2010
Using oligonucleotide aptamer probes for immunostaining of formalin-fixed and paraffin-embedded tissuesZihua Zeng, Peng Zhang, Nianxi Zhao, et al.
Journal of Hematopathology|August 12, 2009
The implication of identifying JAK2 ( V617F ) in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosisRandall J Olsen, Cherie H Dunphy, Dennis P O'Malley, et al.
International Journal of Surgical Pathology|November 27, 2020
Local ALK-Positive Histiocytosis With Unusual Morphology and Novel <i>TRIM33-ALK</i> Gene FusionTien Anh N Tran, Kenneth Tou En Chang, Chik Hong Kuick, et al.
Transplantation and Cellular Therapy|May 5, 2021
Comparison of Myeloablative versus Reduced-Intensity Conditioning Regimens in Allogeneic Stem Cell Transplantation Recipients with Acute Myelogenous Leukemia with Measurable Residual Disease-Negative Disease at the Time of Transplantation: A Retrospective Cohort StudyJames Yu, Yuan Du, Sarfraz Ahmad, et al.
American Journal of Clinical Pathology|September 17, 2008
p38 mitogen-activated protein kinase has different degrees of activation in myeloproliferative disorders and myelodysplastic syndromesMunir Shahjahan, Cherie H Dunphy, April Ewton, et al.
Clinical Transplantation|January 6, 2004
Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorderVasundhara Ganne, Nauman Siddiqi, Bal Kamaplath, et al.
Diagnostic Pathology|September 27, 2006
Prevention of an additional surgery for regional lymphadenectomy in melanoma: rapid intraoperative immunostaining of sentinel lymph node imprint smearsVinod B Shidham, Richard Komorowski, Marcelle Neuberg, et al.
Blood|February 21, 2004
Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemiaMichael D Rosenblum, James L LaBelle, Chung-Che Chang, et al.
Cytojournal|March 24, 2017
Detection of BRAF mutation in the cytocentrifugation supernatant fluid from fine-needle aspiration of thyroid lesions may enhance the diagnostic yieldAshley E Brown, Khin Sandar Lim, George Corpus, et al.
Pageof 11